The difference between iron sorbitol–citric acid and iron dextran is that the former
**Core Concept**
The question pertains to the pharmacological differences between two intravenous iron preparations, iron sorbitol-citric acid and iron dextran, highlighting their distinct properties and uses in clinical practice.
**Why the Correct Answer is Right**
Iron sorbitol-citric acid and iron dextran are both intravenous iron formulations used to treat iron deficiency anemia. The key difference lies in their formulation, stability, and potential side effects. Iron sorbitol-citric acid is a clear, colorless solution that is less likely to cause anaphylactic reactions compared to iron dextran. This is because iron sorbitol-citric acid has a lower molecular weight and is less likely to interact with immune cells. Additionally, iron sorbitol-citric acid is less likely to cause hypotension and is generally better tolerated by patients.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because iron sorbitol-citric acid and iron dextran differ in their formulation, not their route of administration. Both can be administered intravenously.
**Option B:** This option is incorrect because iron sorbitol-citric acid and iron dextran have different side effect profiles, but this does not relate to their differences in formulation or stability.
**Option C:** This option is incorrect because the difference between iron sorbitol-citric acid and iron dextran does not relate to their molecular weight, but rather their formulation and potential side effects.
**Clinical Pearl / High-Yield Fact**
When choosing between iron sorbitol-citric acid and iron dextran, it is essential to consider the patient's risk of anaphylaxis and potential for hypotension. Iron sorbitol-citric acid may be a better option for patients with a history of anaphylaxis or those at high risk of hypotension.
**Correct Answer: A. Iron sorbitol-citric acid is less likely to cause anaphylactic reactions compared to iron dextran.**